Literature DB >> 25639981

A systematic review found no consistent difference in effect between more and less intensive placebo interventions.

Margrit Fässler1, Karin Meissner2, Jos Kleijnen3, Asbjørn Hróbjartsson4, Klaus Linde2.   

Abstract

OBJECTIVES: It has been suggested that some placebo interventions might be associated with larger clinical effects than others. In a systematic review, we investigated whether there is evidence from direct comparisons in randomized clinical trials including two or more placebo groups supporting this hypothesis. STUDY DESIGN AND
SETTING: Eligible trials were identified through electronic database searches and citation tracking up to February 2013. Placebo interventions in a trial were categorized into a more intense and a less intense intervention based on complexity, invasiveness, or route of administration and time needed for application.
RESULTS: Twelve studies with 1,059 patients receiving placebo met the eligibility criteria. Studies were highly heterogeneous regarding patients, interventions, outcomes, and risk of bias. Seven studies did not find any significant differences between the more intense and the less intense placebo intervention, four studies found differences for single outcomes, and one study consistently reported significantly larger effects of the more intense placebo. An explorative meta-analysis yielded a standardized mean difference -0.22 (95% confidence interval: -0.46, 0.02; P = 0.07; I(2) = 68%).
CONCLUSION: In the studies included in this review, more intense placebos were not consistently associated with larger effects than less intense placebos.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Placebo effect; Placebos; Randomized controlled trial; Systematic review; Therapy; Treatment outcome

Mesh:

Substances:

Year:  2014        PMID: 25639981     DOI: 10.1016/j.jclinepi.2014.11.018

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

Review 1.  Placebo Medication and Sham Surgery Responses in Benign Prostatic Hyperplasia Treatments: Implications for Clinical Trials.

Authors:  Igor Sorokin; Adam Schatz; Charles Welliver
Journal:  Curr Urol Rep       Date:  2015-10       Impact factor: 3.092

Review 2.  Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation.

Authors:  Matthew J Burke; Ted J Kaptchuk; Alvaro Pascual-Leone
Journal:  Ann Neurol       Date:  2019-01-08       Impact factor: 10.422

Review 3.  Control interventions in randomised trials among people with mental health disorders.

Authors:  Erlend Faltinsen; Adnan Todorovac; Laura Staxen Bruun; Asbjørn Hróbjartsson; Christian Gluud; Mickey T Kongerslev; Erik Simonsen; Ole Jakob Storebø
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

Review 4.  Placebo Effects in Traumatic Brain Injury.

Authors:  Ginger Polich; Mary Alexis Iaccarino; Ted J Kaptchuk; Leon Morales-Quezada; Ross Zafonte
Journal:  J Neurotrauma       Date:  2018-04-05       Impact factor: 5.269

5.  (Un)Great Expectations: The Role of Placebo Effects in Cognitive Training.

Authors:  Nancy Tsai; Martin Buschkuehl; Snigdha Kamarsu; Priti Shah; John Jonides; Susanne M Jaeggi
Journal:  J Appl Res Mem Cogn       Date:  2018-08-03

6.  Expectations about the effectiveness of pain- and itch-relieving medication administered via different routes.

Authors:  K J Peerdeman; J Tekampe; A I M van Laarhoven; H van Middendorp; R C A Rippe; M L Peters; A W M Evers
Journal:  Eur J Pain       Date:  2017-12-20       Impact factor: 3.931

7.  Contextually Aided Recovery (CARe): a scientific theory for innate healing.

Authors:  Dave Newell; Lise R Lothe; Timothy J L Raven
Journal:  Chiropr Man Therap       Date:  2017-02-13

Review 8.  Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia.

Authors:  Neal Shore; Ronald Tutrone; Claus G Roehrborn
Journal:  Ther Adv Urol       Date:  2019-01-14

9.  Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.

Authors:  Andrea W M Evers; Luana Colloca; Charlotte Blease; Marco Annoni; Lauren Y Atlas; Fabrizio Benedetti; Ulrike Bingel; Christian Büchel; Claudia Carvalho; Ben Colagiuri; Alia J Crum; Paul Enck; Jens Gaab; Andrew L Geers; Jeremy Howick; Karin B Jensen; Irving Kirsch; Karin Meissner; Vitaly Napadow; Kaya J Peerdeman; Amir Raz; Winfried Rief; Lene Vase; Tor D Wager; Bruce E Wampold; Katja Weimer; Katja Wiech; Ted J Kaptchuk; Regine Klinger; John M Kelley
Journal:  Psychother Psychosom       Date:  2018-06-12       Impact factor: 17.659

10.  Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.

Authors:  Neal Shore; Ronald Tutrone; Mitchell Efros; Mohamed Bidair; Barton Wachs; Susan Kalota; Sheldon Freedman; James Bailen; Richard Levin; Stephen Richardson; Jed Kaminetsky; Jeffrey Snyder; Barry Shepard; Kenneth Goldberg; Alan Hay; Steven Gange; Ivan Grunberger
Journal:  World J Urol       Date:  2018-01-29       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.